Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00513214
Status:
COMPLETED
Last Update Posted:
2011-10-04
First Post:
2007-08-07
Brief Title:
Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
Sponsor:
XOMA US LLC
Organization:
XOMA US LLC
Study Overview
Official Title:
A Phase 12a Double-blind Placebo-controlled Study of the Safety and Pharmacokinetics of XOMA 052 in Subjects With Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2011-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and pharmacokinetics PK of XOMA 052 in subjects with stable Type 2 Diabetes Mellitus T2D
The study is a dose-escalation study designed to evaluate route of administration intravenous or subcutaneous doses and dosing regimens for future studies
The study is a dose-escalation study designed to evaluate route of administration intravenous or subcutaneous doses and dosing regimens for future studies
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None